Regarding "A novel molecular mechanism to account for the action of simvastatin against limb ischemia".
Namazi
Hamid
H
D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D004730:Endothelium, Vascular / Q000187:drug effects / Q000276:immunology; D006614:Hindlimb; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D007511:Ischemia / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D016169:Lymphocyte Function-Associated Antigen-1 / Q000378:metabolism; D018482:Muscle, Skeletal / Q000098:blood supply*; D020556:Neutrophil Infiltration / Q000187:drug effects*; D009504:Neutrophils / Q000187:drug effects* / Q000276:immunology; D019821:Simvastatin / Q000494:pharmacology* / Q000627:therapeutic use
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D016169:Lymphocyte Function-Associated Antigen-1; D018799:Intercellular Adhesion Molecule-1; D019821:Simvastatin